Assistant Professor, Medicine - Blood and Marrow Transplantation, Stanford University Medical Center
Hematology
Dr. David B. Miklos, MD
|
|
Give Review
David Miklos practices Hematology. He went to Yale University School of Medicine. Yale University School of Medicine is a top medical university. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor David B. Miklos, MD is a published MD. He has 37 publications published. The most current publication "SNPs and prognosis of GvHD before HCT: any progress?" David Miklos accepts Medicare payments and is listed with Medicare.gov.
Publications
- Risks and benefits of sex-mismatched hematopoietic Cell transplantation differ according to conditioning strategy.
- ABO Mismatch Is Associated with Increased Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation.
- Allogeneic HY antibodies detected 3 months after female to male sex-mismatched HCT predict chronic GVHD and non-relapse mortality.
- Therapeutic benefits targeting B-cells in chronic Graft-versus-host disease.
- A Reduced-Toxicity Regimen Is Associated with Durable EnGraftment and Clinical Cure of Nonmalignant Genetic Diseases among Children Undergoing Blood and Marrow Transpl...
- Total lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with Myelodysplastic syndromes and myeloproliferative neopla...
- Risk associations between HLA-DPB1 T-Cell epitope matching and outcome of unrelated hematopoietic Cell transplantation are independent of HLA-DPA1.
- Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-Transplantatio...
- Clinical impact of H-Y alloimmunity.
- A distinct evolution of the T cell repertoire categorizes treatment refractory gastrointestinal Acute graft-versus-host disease.
- Minimal residual disease quantification using consensus primers and high-throughput igh sequencing predicts post-transplant relapse in chronic lymphocytic Leukemia.
- H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic Graft vs. host disease.
- High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic Leukemia and immune reconstitution assessment.
- A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic Graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.
- Combined CD4 T-Cell and Antibody Response to Human Minor Histocompatibility Antigen DBY After Allogeneic Stem-Cell Transplantation.
- B Cells promote insulin resistance through modulation of T Cells and production of pathogenic IgG antibodies.
- Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal Disease.
- Recombinant antigen microarrays for serum/plasma antibody detection.
- Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic Cell transplantation in recurrent and refractory...
- Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements.
- Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation.
- Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing.
- Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of alloGraft loss in pediatric renal transplant recipients.
- TLI and ATG conditioning with low risk of Graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and un...
- Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures.
- B Cells and transplantation: an educational resource.
- H-Y antibody development associates with Acute rejection in female patients with male kidney transplants.
- Renal pathology in hematopoietic Cell transplantation recipients.
- Toward biomarkers for chronic Graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic Graft-v...
- Antibody responses to H-Y minor histocompatibility antigens correlate with chronic Graft-versus-host disease and disease remission.
- Minor histocompatibility antigen DBY elicits a coordinated B and T Cell response after allogeneic stem Cell transplantation.
- Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem Cell transplantation and in healthy female donors.
- Sirolimus, tacrolimus, and low-dose methotrexate for Graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation.
- A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem Cell transplantation.
- European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with Acute myeloid leukemia undergoing allogeneic hematopoiet...
- SNPs and prognosis of GvHD before HCT: any progress?
Schools
Yale University
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Coagulation Disorders (incl. Hemophilia)
- Deep Vein Thrombosis (DVT)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Select PPO
- Access Plus Savenet
- Basic Exclusive PPO for Small Business
- Basic PPO
- Cigna HMO
- Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Covered California - Bronze PPO
- Health Net PPO
- Individual and Family PPO
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Brigham and Women's Hospital -
Yale University School of Medicine
Hospital
-
Lucile Packard Children's Hospital Stanford -
Stanford Health Care
Drug Facts
| NPI NUMBER | 1982751053 | |
| NPPES Provider LastName | MIKLOS | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 943052200 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 569.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982751053 |
| Last Name Of The Provider | MIKLOS |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Robert S. Negrin, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Linda M. Boxer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shruti N. Sheth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracy I. George, MD |
|
|
Dr. James M. Ford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruno C. Medeiros, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Herbert Kaizer, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Kitsada Wudhikarn, MD |
|
|
Dr. William M. Rogoway, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brent T. Tan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Caroline J. Temmins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ginna G. Laport, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Lowsky, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sally Arai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oyebimpe O. Adesina, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark P. Chao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert W. Hsieh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Iberri, MD |
|
|
Dr. Melanie C. Majure, MD |
|
|
Dr. Richard A. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Cascio, MD
This Doctor is OpenDoctor Recommended.
|